Abcodia, the creator of a new ovarian cancer screening technology, has raised £5.25m from existing investors Albion Ventures and new investors Scottish Equity Partners (SEP) and Cambridge Innovation Capital (CIC).
Company has raised $9m in total at the series-A stage, from new and existing investors
GP is currently investing via MCH Iberian Capital Fund V, which held a €200m first close in April 2020
Existing investors, including Three Hills Capital Partners, will retain a minority share
Capital D acquired Invincible Brands for an undisclosed sum in January 2018